Pages that link to "Q52486321"
Jump to navigation
Jump to search
The following pages link to p53: a frequent target for genetic abnormalities in lung cancer. (Q52486321):
Displayed 50 items.
- What Controls Variation in Human Skin Color? (Q21092842) (← links)
- Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis (Q22010984) (← links)
- Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene (Q24298218) (← links)
- Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen (Q24603984) (← links)
- Molecular biology of lung cancer: clinical implications (Q24610335) (← links)
- Somatic mutations affect key pathways in lung adenocarcinoma (Q24648102) (← links)
- Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma (Q24649847) (← links)
- Characterizing the cancer genome in lung adenocarcinoma (Q24649926) (← links)
- Lung cancer. 1: prevention of lung cancer (Q24678926) (← links)
- New molecularly targeted therapies for lung cancer (Q24680988) (← links)
- Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies (Q26750380) (← links)
- From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers (Q26771375) (← links)
- Origins, genetic landscape, and emerging therapies of small cell lung cancer (Q26798218) (← links)
- DNA damage in inflammation-related carcinogenesis and cancer stem cells (Q26992346) (← links)
- Can microRNAs improve the management of lung cancer patients? A clinician's perspective (Q26999304) (← links)
- Smoking, p53 mutation, and lung cancer (Q27014977) (← links)
- Refined solution structure of the oligomerization domain of the tumour suppressor p53 (Q27730292) (← links)
- Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer (Q27851809) (← links)
- Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription (Q28187745) (← links)
- Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers (Q28214439) (← links)
- Antioncogenes and human cancer (Q28237050) (← links)
- Comprehensive molecular profiling of lung adenocarcinoma (Q28244995) (← links)
- Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation (Q28247699) (← links)
- Bronchopulmonary neuroendocrine tumors (Q28279774) (← links)
- Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments (Q28345648) (← links)
- Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover (Q28360922) (← links)
- Pulmonary adenocarcinoma: a renewed entity in 2011 (Q28395348) (← links)
- Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene (Q28565834) (← links)
- Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex (Q28584078) (← links)
- P53, cell cycle control and apoptosis: Implications for cancer (Q28611435) (← links)
- A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer (Q28710293) (← links)
- Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53 (Q28771765) (← links)
- Genome-wide analysis of DNA copy-number changes using cDNA microarrays (Q29618942) (← links)
- Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice (Q30235460) (← links)
- Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer (Q30419853) (← links)
- Molecular genetics of neurological tumours (Q30495393) (← links)
- Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers (Q30499489) (← links)
- Asbestos and mesothelioma: genetic lessons from a tragedy (Q30530827) (← links)
- Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis (Q30531015) (← links)
- Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus (Q30743997) (← links)
- A note from history: Landmarks in history of cancer, part 7. (Q30931923) (← links)
- FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations (Q32061854) (← links)
- Isolation of DNA sequences deleted in lung cancer by genomic difference cloning (Q33191672) (← links)
- Gene therapy of lung cancer (Q33193343) (← links)
- Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance (Q33665928) (← links)
- Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray (Q33689991) (← links)
- Amplification of chromosomal segment 4q12 in non-small cell lung cancer (Q33708516) (← links)
- Mechanisms of p53 loss in human sarcomas (Q33722859) (← links)
- Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. (Q33740135) (← links)
- Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma (Q33772796) (← links)